| Literature DB >> 34256011 |
Richa B Shah1, Jennifer L Kernan1, Anya van Hoogstraten1, Kiyohiro Ando1, Yuanyuan Li1, Alicia L Belcher1, Ivy Mininger1, Andrei M Bussenault1, Renuka Raman1, Ramanagouda Ramanagoudr-Bhojappa2, Tony T Huang3, Alan D D'Andrea4, Settara C Chandrasekharappa2, Aneel K Aggarwal5, Ruth Thompson6, Samuel Sidi7.
Abstract
Cells counter DNA damage through repair or apoptosis, yet a direct mechanism for this choice has remained elusive. When facing interstrand crosslinks (ICLs), the ICL-repair protein FANCI heterodimerizes with FANCD2 to initiate ICL excision. We found that FANCI alternatively interacts with a pro-apoptotic factor, PIDD1, to enable PIDDosome (PIDD1-RAIDD-caspase-2) formation and apoptotic death. FANCI switches from FANCD2/repair to PIDD1/apoptosis signaling in the event of ICL-repair failure. Specifically, removing key endonucleases downstream of FANCI/FANCD2, increasing ICL levels, or allowing damaged cells into mitosis (when repair is suppressed) all suffice for switching. Reciprocally, apoptosis-committed FANCI reverts from PIDD1 to FANCD2 after a failed attempt to assemble the PIDDosome. Monoubiquitination and deubiquitination at FANCI K523 impact interactor selection. These data unveil a repair-or-apoptosis switch in eukaryotes. Beyond ensuring the removal of unrepaired genomes, the switch's bidirectionality reveals that damaged cells can offset apoptotic defects via de novo attempts at lesion repair.Entities:
Keywords: DNA interstrand crosslink; DNA repair; FANCD2; FANCI; PIDD1; PIDDosome; apoptosis; molecular switch; monoubiquitination; repair failure
Mesh:
Substances:
Year: 2021 PMID: 34256011 PMCID: PMC8378530 DOI: 10.1016/j.devcel.2021.06.010
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 13.417